跳至主要内容
临床试验/CTRI/2022/07/043892
CTRI/2022/07/043892尚未招募未知

Etomidate versus propofol as sedative for ERCP - A prospective randomized controlled trial

itin mantri0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ASA grade I -II undergoing ERCP in Institute of Liver and Biliary Sciences New Delhi

排除标准

  • 1.Patient refusal
  • 2.Chronic sedative or opioid analgesic use
  • 3.Known allergy to the study drugs
  • 4.Uncontrolled Hypertension
  • 5.Uncontrolled Diabetes
  • 6.Presence of Cirrhosis (on imaging +/- histology)
  • 7.Post liver transplant recipients
  • 8.Heart failure (ejection fraction <40%,NYHA IV)
  • 9.Severe respiratory disease (FEV1 <50%,FVC <50%)
  • 10.Porphyria
  • 11.Pre-existing epilepsy
  • 12.Pregnancy
  • 13.Lactation
  • 14.Procedure more than 60 min
  • 15.Patients with known adrenocortical insufficiency

研究者

发起方
itin mantri

相似试验